ClinicalTrials.Veeva

Menu
T

The Retina Group of Washington | Fairfax, Virginia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pegcetacoplan
APL-2
bevacizumab
zeaxanthin
ranibizumab
DHA
EPA

Parent organization

This site is a part of The Retina Group of Washington

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 9 total trials

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (GALE)

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

Trial sponsors

A
A
National Institutes of Health (NIH) logo
Notal Vision logo
The EMMES Corporation logo
T
University of Pennsylvania logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems